Approval · Notice of Compliance 23982 · 2020
ANTHIM: Notice of Compliance 23982
Issued July 30, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23982
- Date
- July 30, 2020
- Company
- Elusys Therapeutics IncBoca Raton, Florida, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANTHIM | 02502895 | Restricted Access |
Medicinal ingredients
- OBILTOXAXIMAB 100 MG per ML